Patent application number | Description | Published |
20120043391 | SPRAY DEVICE - A spray device for connection to a reservoir of fluid for spraying, the spray device includes a dosing chamber for holding fluid; a connector for fluidly connecting the dosing chamber to the reservoir; a piston moveable from a first end of the dosing chamber to a second end of the dosing chamber so as to draw into the dosing chamber fluid from the reservoir; a spring biasing the piston towards said first end; a plunger, actuable by a user, to move the piston towards said second end against the bias of the spring; a nozzle for spraying fluid; and a user-actuable valve for selectively fluidly connecting the dosing chamber to the nozzle. | 02-23-2012 |
20120255950 | FLUID PACKAGING CONTAINER - Fluid packaging container of substantially rigid, or semi rigid construction. The container being configured to be operatively connectable to a beverage dispensing station. The fluid packaging container defines an interior space and contains a first volume of a liquid ingredient and a second volume of gas. In use the first and second volumes are each variable between a volume of substantially zero and a volume corresponding substantially to the interior space and being complementary to one another. Thereby the first and second volume together fill the interior space. The fluid packaging container in particular includes a fluid outlet arranged to communicate with the beverage dispensing station and pressure equalizing means for maintaining a predefined pressure in the second volume, irrespective of liquid withdrawn from the interior space. | 10-11-2012 |
20130056547 | PARTICULATE SPRAYER - A particulate sprayer includes a gas reservoir to hold a gas, a liquid reservoir to hold a product, and a low pressure section including an exit opening connected to the liquid reservoir. The product includes a liquid and solid particles. The low pressure section transports gas released from the gas reservoir over the exit opening. The product is drawn, pushed, or drawn and pushed from the exit opening into the transported gas to create a spray of the product to be sprayed from the particulate sprayer. | 03-07-2013 |
20150050392 | METHOD AND SYSTEM FOR PROVIDING DRINKS, DRINKS CONTAINER AND DRINKS DEVICE - Method and system of using a drinks device to provide a variety of different types of drink requiring respective mixes of components and water. Drinks containers are arranged to each house separately the required components of a respective drink. Each drinks container is provided with a respective delivery outlet for dispensing a mix of the respective housed components. The drinks device is used to act upon respective drinks containers so as to mix the separately housed components and dispense the mixed components from the respective delivery outlet in conjunction with water from a water dispenser of the drinks device. | 02-19-2015 |
20150129674 | PARTICULATE SPRAYER - A particulate sprayer includes a gas reservoir to hold a gas, a liquid reservoir to hold a product, and a low pressure section including an exit opening connected to the liquid reservoir. The product includes a liquid and solid particles. The low pressure section transports gas released from the gas reservoir over the exit opening. The product is drawn, pushed, or drawn and pushed from the exit opening into the transported gas to create a spray of the product to be sprayed from the particulate sprayer. | 05-14-2015 |
Patent application number | Description | Published |
20120015927 | CRYSTALLINE FORMS OF N-[2-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-6--4-PYRIMIDINYL]-1-AZETIDINESULF- ONAMIDE - There is provided crystalline forms of N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-{[(1R,2S)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]1-azetidinesulfon-amide anhydrate. Such compounds/forms may be useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial. | 01-19-2012 |
20130203991 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators - A compound of formula (I), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders. | 08-08-2013 |
20140235606 | CRYSTALLINE FORMS OF N-[2-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-6--4-PYRIMIDINYL]-1-AZETIDINESULF- ONAMIDE - There is provided crystalline forms of N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-{[(1R,2S)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfon-amide anhydrate. Such compounds/forms may be useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial. | 08-21-2014 |
Patent application number | Description | Published |
20090239882 | Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor Activity - A compound of formula (I), or a pharmaceutically acceptable salt, or solvate thereof; and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders. | 09-24-2009 |
20110124619 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators - A compound of formula (I), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders. | 05-26-2011 |
20120157431 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators - A compound of formula (I), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders. | 06-21-2012 |
20130012490 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators - A compound of formula (1), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders. | 01-10-2013 |